Contrary to their expected findings, they found that established AKI patients, compared to controls, had significantly greater DNA methylation of KLK1 as expected but also had significantly higher levels of urine excreted kallikrein, which was not expected. This evidence concerns the gene KLK1 and acute kidney injury.